Pharmaceutical companies that received portions of the R3.6 billion antiretroviral drugs tenders to supply the government last year are divided on their experiences thus far. On Monday Aspen Pharmacare said it was disappointed at the way the government had handled the tender. Yesterday MSD said forecast and planning of stock was "very difficult". GlaxoSmithKline said it had some challenges that the government was addressing. Adcock Ingram, Cipla Medpro and Sonke Pharmaceuticals were happy with the way the government was managing the contract. - Slindile Khanyile
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
